Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
depression
3
×
blackstone group
boston
boston blog main
boston top stories
clinical trials
david goldstein
epilepsy
essential tremor
kiran reddy
life sciences
major depressive disorder
national blog main
national top stories
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
steven petrou
aligos therapeutics
antisense oligonucleotide
baker brothers life sciences
benzodiazepine
benzodiazepines
biogen
biomarkers
biotech ipos
blackstone life sciences
blepharitis
cavion
cephalgia
chronic hepatitis b virus
columbia university
demodex blepharitis
drug development
epi4k
eventide asset management
fda
health
What
precision
3
×
research
drugs
medicines
praxis
aims
alto
announced
backed
biotechs
cause
central
ceo
cerebral
clinical
cns
decentralized
depression
disorder
earnest
embarked
emerged
epilepsy
forced
forefront
genes
genetic
health
home
horizon
ipos
kept
leads
links
marcio
mental
mutations
nervous
neuro
neuroscience
Language
unset
Current search:
biotech
×
depression
×
precision
×
@techcrunch.com
2 years ago
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
